Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenstrom macroglobulinemia

被引：16
|
作者：
Castillo, Jorge J. [1 ,2 ]
Gustine, Joshua N. [1 ]
Meid, Kirsten [1 ]
Dubeau, Toni E. [1 ]
Xu, Lian [1 ]
Yang, Guang [1 ,2 ]
Hunter, Zachary R. [1 ]
Advani, Ranjana [3 ]
Palomba, Lia [4 ]
Treon, Steven P. [1 ,2 ]
机构：
[1] Dana Farber Canc Inst, Bing Ctr Waldenstrom Macroglobulinemia, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 10期
关键词：
MYD88;
D O I：
10.3324/haematol.2018.191999
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E466 / E468
页数：3
相关论文
共 50 条
  • [31] Multicenter Prospective Phase II Study of Venetoclax in Patients with Previously Treated Waldenstrom Macroglobulinemia
    Castillo, Jorge J.
    Gustine, Joshua
    Meid, Kirsten
    Dubeau, Toni
    Keezer, Andrew
    Allan, John N.
    Furman, Richard R.
    Siddiqi, Tanya
    Advani, Ranjana
    Lam, Jessica
    Hunter, Zachary R.
    Yang, Guang
    Xu, Lian
    Davids, Matthew S.
    Treon, Steven P.
    BLOOD, 2018, 132
  • [32] Rituximab therapy in previously treated Waldenstrom's macroglobulinemia: Preliminary evidence of activity.
    Byrd, JC
    White, CA
    Link, B
    Thomas, S
    Valasquez, WS
    Rosenberg, J
    Grillo-Lopez, AJ
    BLOOD, 1998, 92 (10) : 106A - 106A
  • [33] Multicenter prospective phase II study of venetoclax in patients with previously treated Waldenstrom macroglobulinemia
    Castillo, Jorge
    Allan, John
    Siddiqi, Tanya
    Advani, Ranjana
    Keezer, Andrew
    Gustine, Joshua
    Meid, Kirsten
    Dubeau, Toni
    Lam, Jessica
    Xu, Lian
    Yang, Guang
    Hunter, Zachary
    Furman, Richard
    Davids, Matthew
    Treon, Steven
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E39 - E40
  • [34] Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenstrom macroglobulinemia
    Castillo, Jorge J.
    Libby, Edward N.
    Ansell, Stephen M.
    Palomba, M. Lia
    Meid, Kirsten
    Flynn, Catherine A.
    Leventoff, Carly
    Hergott, Christopher B.
    Sewastianik, Tomasz
    Morgan, Elizabeth A.
    Carrasco, Ruben
    Fromm, Jonathan R.
    Yang, Guang
    Hunter, Zachary
    Treon, Steven P.
    BLOOD ADVANCES, 2020, 4 (20) : 5089 - 5092
  • [35] Fludarabine therapy in Waldenstrom's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine
    Lewandowski, K
    Halaburda, K
    Hellmann, A
    LEUKEMIA & LYMPHOMA, 2002, 43 (02) : 361 - 363
  • [36] COMPARISON OF HEALTHCARE RESOURCE UTILIZATION AND COSTS FOR WALDENSTROM'S MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB OR CHEMOIMMUNOTHERAPY
    Iyengar, R.
    Malangone-Monaco, E.
    Sugg, C.
    Arango-Hisijara, I
    Chen, Z.
    DeYoung, K.
    Chan, C.
    Giafis, N.
    VALUE IN HEALTH, 2019, 22 : S76 - S76
  • [37] Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia
    Nalin, Ansel
    Zhao, Qiuhong
    Voorhees, Timothy
    Bond, David
    Sawalha, Yazeed
    Hanel, Walter
    Sigmund, Audrey
    Annunzio, Kaitlin
    Alinari, Lapo
    Baiocchi, Robert
    Maddocks, Kami
    Jones, Dan
    Christian, Beth
    Epperla, Narendranath
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] Impact of Chemotherapy Dose Intensity on Cancer Patient Outcomes
    Lyman, Gary H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (01): : 99 - 108
  • [39] Mutated MYD88 Homozygosity Is Increased in Previously Treated Patients with Waldenstrom's Macroglobulinemia, and Associates with CXCR4 Mutation Status and Ibrutinib Exposure
    Tsakmaklis, Nickolas
    Xu, Lian
    Manning, Robert
    Yang, Guang
    Liu, Xia
    Chen, Jiaji
    Demos, Maria
    Kofides, Amanda
    Chan, Gloria
    Guerrera, Maria Luisa
    Patterson, Christopher
    Castillo, Jorge J.
    Treon, Steven P.
    Hunter, Zachary
    BLOOD, 2017, 130
  • [40] A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenstrom Macroglobulinemia
    Ghobrial, Irene M.
    Moreau, Philippe
    Harris, Brianna
    Poon, Tiffany
    Jourdan, Eric
    Maisonneuve, Herve
    Benhadji, Karim A.
    Hossain, Anwar M.
    Nguyen, Tuan S.
    Wooldridge, James E.
    Leblond, Veronique
    CLINICAL CANCER RESEARCH, 2012, 18 (18) : 5043 - 5050
12345